We are live on ! Find out more
NG

NatWest Group Portfolio holdings

AUM $462M
1-Year Est. Return 47.31%
This Fund
S&P 500
This Quarter Est. Return
-4.07%
1 Year Est. Return
+47.31%
3 Year Est. Return
+185.58%
5 Year Est. Return
+231.38%
10 Year Est. Return
+745.17%
AUM
$172M
AUM Growth
-$3.98M
Cap. Flow
+$3.65M
Cap. Flow %
2.12%
Top 10 Hldgs %
48.03%
Holding
56
New
7
Increased
9
Reduced
25
Closed
6

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.89M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.44M
3
WRB icon
W.R. Berkley
WRB
+$5.43M
4
PWR icon
Quanta Services
PWR
+$5.24M
5
LLY icon
Eli Lilly
LLY
+$5.11M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$4.39M
2
ORLY icon
O'Reilly Automotive
ORLY
+$3.49M
3
UNP icon
Union Pacific
UNP
+$3.26M
4
AXP icon
American Express
AXP
+$3.12M
5
CTAS icon
Cintas
CTAS
+$3M

Sector Composition

Rank Sector Weight
1 Technology 30.08%
2 Financials 16.8%
3 Healthcare 14.6%
4 Consumer Discretionary 9.4%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$15.6M 9.06%
112,918
+37,522
+50% +$5.89M
MSFT icon
2
Microsoft
MSFT
$2.93T
$13.8M 7.99%
59,092
+10,038
+20% +$2.65M
CME icon
3
CME Group
CME
$88.5B
$10.6M 6.17%
60,001
UNH icon
4
UnitedHealth
UNH
$387B
$7.55M 4.39%
14,955
+579
+4% +$304K
MCD icon
5
McDonald's
MCD
$190B
$6.54M 3.8%
28,345
+9,698
+52% +$2.48M
KLAC icon
6
KLA
KLAC
$278B
$6.3M 3.66%
208,030
+6,690
+3% +$232K
CF icon
7
CF Industries
CF
$18.7B
$5.95M 3.45%
61,792
-13,161
-18% -$1.28M
COST icon
8
Costco
COST
$417B
$5.53M 3.21%
11,708
-2,223
-16% -$1.16M
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$123B
$5.48M 3.18%
+18,918
New +$5.44M
WRB icon
10
W.R. Berkley
WRB
$26.7B
$5.38M 3.12%
+124,974
New +$5.43M
LLY icon
11
Eli Lilly
LLY
$1.05T
$5.21M 3.03%
+16,114
New +$5.11M
GIS icon
12
General Mills
GIS
$20.3B
$5.13M 2.98%
+66,913
New +$5.1M
ORLY icon
13
O'Reilly Automotive
ORLY
$71.3B
$5.09M 2.95%
108,525
-74,880
-41% -$3.49M
IVV icon
14
iShares Core S&P 500 ETF
IVV
$881B
$5.02M 2.91%
13,991
PWR icon
15
Quanta Services
PWR
$94.3B
$4.88M 2.84%
+38,334
New +$5.24M
ATVI
16
DELISTED
Activision Blizzard
ATVI
$4.86M 2.82%
65,310
-4,180
-6% -$327K
CTAS icon
17
Cintas
CTAS
$81.8B
$4.6M 2.67%
47,432
-29,364
-38% -$3M
AVGO icon
18
Broadcom
AVGO
$1.76T
$4.52M 2.62%
101,790
+9,530
+10% +$487K
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$4.23T
$3.89M 2.26%
40,661
-16,859
-29% -$1.87M
AMGN icon
20
Amgen
AMGN
$198B
$3.6M 2.09%
15,956
-2,534
-14% -$614K
AXP icon
21
American Express
AXP
$242B
$3.28M 1.91%
24,323
-20,619
-46% -$3.12M
JPM icon
22
JPMorgan Chase
JPM
$907B
$3.26M 1.89%
31,151
-7,259
-19% -$833K
XEL icon
23
Xcel Energy
XEL
$49.2B
$3.11M 1.81%
48,630
+23,173
+91% +$1.69M
NKE icon
24
Nike
NKE
$64.9B
$2.73M 1.59%
32,888
-24,108
-42% -$2.6M
NVDA icon
25
NVIDIA
NVDA
$4.91T
$2.57M 1.49%
211,880
-48,260
-19% -$763K

Similar funds

NatWest Group's Q3 2022 Portfolio in Review

As of Q3 2022, NatWest Group held 56 positions worth $172M, down 2.3% from $176M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

NatWest Group's Q3 2022 filing shows 7 new, 9 increased, 25 reduced and 6 closed positions. Its largest new stake was Vertex Pharmaceuticals: 18,918 shares worth $5.48M. The largest sale was Estee Lauder, an estimated $4.39M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • NatWest Group's largest Q3 2022 buy was Vertex Pharmaceuticals: 18,918 shares worth $5.48M.
  • NatWest Group added most to Apple in Q3 2022, an estimated $5.89M increase.
  • NatWest Group's biggest Q3 2022 reduction was Estee Lauder, cutting an estimated $4.39M.
  • NatWest Group fully exited Ross Stores in Q3 2022, selling an estimated $1.74M.
  • NatWest Group's ten largest holdings make up 48% of its $172M portfolio in Q3 2022.
  • NatWest Group opened 7 new positions and closed 6 in Q3 2022.
  • NatWest Group's portfolio value fell 2.3% quarter-over-quarter to $172M.

Based on NatWest Group's 13F filing for Q3 2022, filed 31 Oct 2022.